183 related articles for article (PubMed ID: 33212380)
1. ADAMTS13 activity, high VWF and FVIII levels in the pathogenesis of deep vein thrombosis.
Pagliari MT; Boscarino M; Cairo A; Mancini I; Martinelli I; Bucciarelli P; Rossi F; Rosendaal FR; Peyvandi F
Thromb Res; 2021 Jan; 197():132-137. PubMed ID: 33212380
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms and mutations in vWF and ADAMTS13 genes and their correlation with plasma levels of FVIII and vWF in patients with deep venous thrombosis.
Bittar LF; de Paula EV; Mello TB; Siqueira LH; Orsi FL; Annichino-Bizzacchi JM
Clin Appl Thromb Hemost; 2011 Oct; 17(5):514-8. PubMed ID: 20682599
[TBL] [Abstract][Full Text] [Related]
3. Role of ADAMTS13, VWF and F8 genes in deep vein thrombosis.
Pagliari MT; Cairo A; Boscarino M; Mancini I; Pappalardo E; Bucciarelli P; Martinelli I; Rosendaal FR; Peyvandi F
PLoS One; 2021; 16(10):e0258675. PubMed ID: 34662354
[TBL] [Abstract][Full Text] [Related]
4. Influences of ABO blood group, age and gender on plasma coagulation factor VIII, fibrinogen, von Willebrand factor and ADAMTS13 levels in a Chinese population.
Wang Z; Dou M; Du X; Ma L; Sun P; Cao H; Ye S; Jiang P; Liu F; Lin F; Zhang R; Li C
PeerJ; 2017; 5():e3156. PubMed ID: 28382235
[TBL] [Abstract][Full Text] [Related]
5. von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis.
Nossent AY; VAN Marion V; VAN Tilburg NH; Rosendaal FR; Bertina RM; VAN Mourik JA; Eikenboom HC
J Thromb Haemost; 2006 Dec; 4(12):2556-62. PubMed ID: 17059421
[TBL] [Abstract][Full Text] [Related]
6. Next-generation sequencing study finds an excess of rare, coding single-nucleotide variants of ADAMTS13 in patients with deep vein thrombosis.
Lotta LA; Tuana G; Yu J; Martinelli I; Wang M; Yu F; Passamonti SM; Pappalardo E; Valsecchi C; Scherer SE; Hale W; Muzny DM; Randi G; Rosendaal FR; Gibbs RA; Peyvandi F
J Thromb Haemost; 2013 Jul; 11(7):1228-39. PubMed ID: 23648131
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the Diagnostic Value of Plasma Levels, Activities, and Their Ratios of von Willebrand Factor and ADAMTS13 in Patients with Cerebral Infarction.
Qu L; Jiang M; Qiu W; Lu S; Zhao Y; Xia L; Ruan C; Zhao Y
Clin Appl Thromb Hemost; 2016 Apr; 22(3):252-9. PubMed ID: 25916953
[TBL] [Abstract][Full Text] [Related]
8. High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor.
Rietveld IM; Lijfering WM; le Cessie S; Bos MHA; Rosendaal FR; Reitsma PH; Cannegieter SC
J Thromb Haemost; 2019 Jan; 17(1):99-109. PubMed ID: 30471183
[TBL] [Abstract][Full Text] [Related]
9. Relationship between ABO blood groups and von Willebrand factor, ADAMTS13 and factor VIII in patients undergoing hemodialysis.
Rios DR; Fernandes AP; Figueiredo RC; Guimarães DA; Ferreira CN; Simões E Silva AC; Carvalho MG; Gomes KB; Dusse LM
J Thromb Thrombolysis; 2012 May; 33(4):416-21. PubMed ID: 22466813
[TBL] [Abstract][Full Text] [Related]
10. ADAMTS13, von Willebrand Factor, Platelet Microparticles, Factor VIII, and Impact of Somatic Mutations in the Pathogenesis of Splanchnic Vein Thrombosis Associated with BCR-ABL-Negative Myeloproliferative Neoplasms.
Castelli R; Berzuini A; Manetti R; Delitala AP; Castro D; Sanna G; Sircana MC; Profili NI; Bartoli A; La Cava L; Lambertenghi Deliliers G; Donadoni M; Gidaro A
Life (Basel); 2024 Apr; 14(4):. PubMed ID: 38672756
[TBL] [Abstract][Full Text] [Related]
11. Rise of levels of von Willebrand factor and factor VIII with age: Role of genetic and acquired risk factors.
Biguzzi E; Castelli F; Lijfering WM; Cannegieter SC; Eikenboom J; Rosendaal FR; van Hylckama Vlieg A
Thromb Res; 2021 Jan; 197():172-178. PubMed ID: 33221577
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of von Willebrand factor and ADAMTS13 in patients with COVID-19: A systematic review and meta-analysis.
Xu X; Feng Y; Jia Y; Zhang X; Li L; Bai X; Jiao L
Thromb Res; 2022 Oct; 218():83-98. PubMed ID: 36027630
[TBL] [Abstract][Full Text] [Related]
13. High factor VIII (FVIII) levels in venous thromboembolism: role of unbound FVIII.
Schambeck CM; Grossmann R; Zonnur S; Berger M; Teuchert K; Spahn A; Walter U
Thromb Haemost; 2004 Jul; 92(1):42-6. PubMed ID: 15213843
[TBL] [Abstract][Full Text] [Related]
14. Levels and activities of von Willebrand factor and metalloproteinase with thrombospondin type-1 motif, number 13 in inflammatory bowel diseases.
Cibor D; Owczarek D; Butenas S; Salapa K; Mach T; Undas A
World J Gastroenterol; 2017 Jul; 23(26):4796-4805. PubMed ID: 28765701
[TBL] [Abstract][Full Text] [Related]
15. Standardisation of factor VIII and von Willebrand factor in plasma: calibration of the 4th International Standard (97/586).
Hubbard AR; Rigsby P; Barrowcliffe TW
Thromb Haemost; 2001 Apr; 85(4):634-8. PubMed ID: 11341497
[TBL] [Abstract][Full Text] [Related]
16. Von Willebrand factor, ADAMTS13 and mortality in dialysis patients.
Ocak G; Roest M; Verhaar MC; Rookmaaker MB; Blankestijn PJ; Bos WJW; Fijnheer R; Péquériaux NC; Dekker FW
BMC Nephrol; 2021 Jun; 22(1):222. PubMed ID: 34134634
[TBL] [Abstract][Full Text] [Related]
17. Long-term increased factor VIII levels are associated to interleukin-6 levels but not to post-thrombotic syndrome in patients with deep venous thrombosis.
Bittar LF; Mazetto Bde M; Orsi FL; Collela MP; De Paula EV; Annichino-Bizzacchi JM
Thromb Res; 2015 Mar; 135(3):497-501. PubMed ID: 25575413
[TBL] [Abstract][Full Text] [Related]
18. Factor VIII accelerates proteolytic cleavage of von Willebrand factor by ADAMTS13.
Cao W; Krishnaswamy S; Camire RM; Lenting PJ; Zheng XL
Proc Natl Acad Sci U S A; 2008 May; 105(21):7416-21. PubMed ID: 18492805
[TBL] [Abstract][Full Text] [Related]
19. Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma.
Lippi G; Franchini M; Salvagno GL; Montagnana M; Poli G; Guidi GC
J Thromb Thrombolysis; 2008 Oct; 26(2):150-3. PubMed ID: 17786534
[TBL] [Abstract][Full Text] [Related]
20. Light chain of factor VIII is sufficient for accelerating cleavage of von Willebrand factor by ADAMTS13 metalloprotease.
Cao W; Sabatino DE; Altynova E; Lange AM; Casina VC; Camire RM; Zheng XL
J Biol Chem; 2012 Sep; 287(39):32459-66. PubMed ID: 22854959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
